Delivery Order SPE2DB22D1017-SPE2DB25FG9DU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.43 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement fulfilled by AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $1,635.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of July 30, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $12,905.95 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract. This non-set-aside award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The sensors will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,031.20 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price contract represents a non-competitive, non-set-aside award for continuous glucose monitoring devices to support federal medical supply needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,120.37 to AmerisourceBergen Drug Corp for Dexcom G7 sensors on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a non-competitive award issued under a larger indefinite delivery contract (IDC) vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a $1,008.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 4, 2025. This is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation, and performance will be executed from...
- The Defense Logistics Agency awarded a $10,283.29 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of Dexcom G6 Sensor 3S continuous glucose monitoring devices, valued at $1,467.90. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract and serves as a critical pharmaceutical and medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9DUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,036.08 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of August 8, 2025. This firm fixed-price contract, issued on August 7, 2025, is a non-set-aside award issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The sensors will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary distribution hub for federal pharmaceutical and medical device procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in the federal medical supply chain through its $999,999,999.00 IDC with DLA Troop Support Medical, which extends through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical devices to support Defense Health Agency and other military healthcare systems globally. The current delivery order for Dexcom G7 continuous glucose monitoring sensors represents a specialized medical device procurement, supporting diabetes management capabilities across federal military and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/7/25 |